Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
World Journal of Urology
Published in: World Journal of Urology 4/2014

01-08-2014 | Original Article

Chest X-ray in the follow-up of renal cell carcinoma

Authors: B. H. J. Doornweerd, I. J. de Jong, L. M. Bergman, H. J. K. Ananias

Published in: World Journal of Urology | Issue 4/2014

Login to get access

Abstract

Purpose

To evaluate the value of chest X-ray in the follow-up of surgically treated T1-3N0M0 renal cell carcinoma.

Methods

We performed retrospective analysis of patients that underwent surgical treatment of a localized renal cell carcinoma (T1-3N0M0) between January 1993 and July 2010. Data on frequency and results of performed chest X-rays were collected from patients’ records.

Results

In 17.5 years, 249 patients with a T1-3N0M0 renal cell carcinoma underwent a radical or partial nephrectomy. In 221 patients, 823 chest X-rays were performed during a median follow-up of 3.3 years (range 0.5–17 years). In 19 patients, a pulmonary recurrence occurred, of which 10 were not detected by the regular follow-up. Of the 9 patients that were diagnosed with a pulmonary recurrence with a chest X-ray during follow-up, 7 were asymptomatic at the time of diagnosis, and the chest X-ray has led to the detection; 0.85 % of the performed chest X-rays (7/823) have led to the detection of asymptomatic lung metastases.

Conclusions

Due to the low yield of chest X-ray for detection of asymptomatic pulmonary recurrences, it has very low clinical value in the follow-up after nephrectomy for T1-3N0M0 renal cell carcinoma.
Literature
1.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin D (2008) GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet] World. Available from: http://​globocan.​iarc.​fr
2.
3.
Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163(2):442–445PubMedCrossRef
4.
Patard J-J, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, Zisman A et al (2004) Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 22(16):3316–3322PubMedCrossRef
5.
6.
Skolarikos A, Alivizatos G, Laguna P, de la Rosette J (2007) A review on follow-up strategies for renal cell carcinoma after nephrectomy. Eur Urol 51(6):1490–1500; discussion 1501PubMedCrossRef
7.
Motzer RJ, Agarwal N, Beard C, Bhayani S, Graeme B, Carducci MA et al (2011) Kidney cancer. J Natl Compr Cancer Netw 9(9):960–977
8.
Basu S, Biyani CS, Sundaram SK, Spencer J (2006) A survey of follow-up practice of urologists across Britain and Ireland following nephrectomy for renal cell carcinoma. Clin Radiol 61(10):854–860; discussion 861–862PubMedCrossRef
9.
Ciatto S, Pacini P, Andreoli C, Cecchini S, Iossa A, Grazzini G et al (1989) Chest X-ray survey in the follow-up of breast cancer patients. Br J Cancer 60(1):102–103PubMedCentralPubMedCrossRef
10.
11.
Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG et al (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24(31):5091–5097PubMedCrossRef
12.
Sobin LH, Gospodarowicz M, Wittekind C (eds) (2010) International union against cancer (UICC) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, Hoboken, NJ
13.
14.
Eble JN, Epstein JI, Sesterhenn IA (2004) World health organization classification of tumours pathology and genetics of tumours of the urinary system and male genital organs. IARC Press, Lyon
15.
Sandock DS, Seftel AD, Resnick MI (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. J Urol 154(1):28–31PubMedCrossRef
16.
Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H (2002) Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 73(4):1082–1087PubMedCrossRef
17.
Hofmann H-S, Neef H, Krohe K, Andreev P, Silber R-E (2005) Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 48(1):77–81; discussion 81–82PubMedCrossRef
18.
Herrmann E, Bierer S, Wülfing C (2010) Update on systemic therapies of metastatic renal cell carcinoma. World J Urol 28(3):303–309PubMedCrossRef
19.
Molina AM, Motzer RJ (2011) Clinical practice guidelines for the treatment of metastatic renal cell carcinoma: today and tomorrow. Oncologist 16(Suppl 2):45–50PubMedCentralPubMedCrossRef
20.
Levy DA, Slaton JW, Swanson DA, Dinney CP (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol 159(4):1163–1167PubMedCrossRef
21.
Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P (2001) A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166(1):63–67PubMedCrossRef
22.
Lam JS, Klatte T, Kim HL, Patard J-J, Breda A, Zisman A et al (2008) Prognostic factors and selection for clinical studies of patients with kidney cancer. Crit Rev Oncol Hematol 65(3):235–262PubMedCrossRef
23.
Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS (2005) Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 174(2):466–472; discussion 472; quiz 801PubMedCrossRef
24.
Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW (2008) Preoperative nomogram predicting 12-year probability of metastatic renal cancer. J Urol 179(6):2146–2151; discussion 2151PubMedCentralPubMedCrossRef
25.
Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S et al (2011) Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol 60(4):644–661PubMedCrossRef
26.
Karakiewicz PI, Briganti A, Chun FK-H, Trinh Q-D, Perrotte P, Ficarra V et al (2007) Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol Off J Am Soc Clin Oncol 25(11):1316–1322CrossRef
27.
Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED et al (2003) Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97(7):1663–1671PubMedCrossRef
28.
Hupertan V, Roupret M, Poisson J-F, Chretien Y, Dufour B, Thiounn N et al (2006) Low predictive accuracy of the Kattan postoperative nomogram for renal cell carcinoma recurrence in a population of French patients. Cancer 107(11):2604–2608PubMedCrossRef
29.
Metadata
Title
Chest X-ray in the follow-up of renal cell carcinoma
Authors
B. H. J. Doornweerd
I. J. de Jong
L. M. Bergman
H. J. K. Ananias
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 4/2014
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-013-1176-2

Other articles of this Issue 4/2014

World Journal of Urology 4/2014 Go to the issue

Topic Paper

The role of biomarkers in the assessment of prostate cancer risk prior to prostate biopsy: Which markers matter and how should they be used?

Original Article

Application of the 2013 American Urological Association early detection of prostate cancer guideline: Who will we miss?

Original Article

Holmium:YAG laser ureteroscopic lithotripsy for ureteric calculi in children: predictive factors for complications and success

Topic Paper

A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center

Original Article

Lower urinary tract symptoms improve with testosterone replacement therapy in men with late-onset hypogonadism: 5-year prospective, observational and longitudinal registry study

Original Article

Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy